Continuous Bioprocessing Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Continuous Bioprocessing Market is Segmented By Type of Manufacturer (Innovator / Drug Developer, Contract Service Provider), By Company Size (Large, Mid-Sized, Small). The report offers the value (in USD million) for the above-mentioned segments.
Continuous Bioprocessing Market Size
Market Size in USD
CAGR8.4%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 8.4% |
| Market Concentration | Medium |
| Major Players | AGC Biologics, Biogen, Bristol-Myers Squibb, Sanofi Genzyme, FUJIFILM Diosynth Biotechnologies |
please let us know !
Continuous Bioprocessing Market Analysis
The continuous bioprocessing market is estimated to be valued at USD 395 Mn in 2024 and is expected to reach USD 695 Mn by 2031, growing at a compound annual growth rate (CAGR) of 8.4% from 2024 to 2031.
Continuous bioprocessing offers various advantages over traditional batch manufacturing which includes higher productivity, reduced operational costs and lesser process development time. This has accelerated the adoption of continuous bioprocessing manufacturing among pharma companies and contract manufacturers. Advancements in sensors and process analytical technology have enabled real-time monitoring of bioprocesses which has further optimized processes and improved yields. Government support and heavy investments by major players to develop novel continuous bioprocessing platforms are also fueling growth of this market.